Systemic levels of the endothelium-derived soluble adhesion molecules endocan and E-selectin in patients with suspected deep vein thrombosis

SpringerPlus

Volumn 3, Issue 1, 2014, Pages

  Mosevoll, Knut Anders ^a   Lindås, Roald ^b   Wendelbo, Øystein ^b   Bruserud, Øystein ^a,b   Reikvam, Håkon ^b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Adhesion molecules; Cytokines; Deep venous thrombosis; Matrix metalloproteases; Venous thromboembolism

Indexed keywords

EID: 84933039526     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-3-571     Document Type: Article

References (24)

1. Bruserud O, Akselen PE, Bergheim J, Nesthus I: Serum concentrations of E-selectin, P-selectin, ICAM-1 and interleukin 6 in acute leukaemia patients with chemotherapy-induced leucopenia and bacterial infections.Br J Haematol 1995,91(2):394–402. 10.1111/j.1365-2141.1995.tb05309.x
2. Bruserud O, Halstensen A, Peen E, Solberg CO: Serum levels of adhesion molecules and cytokines in patients with acute leukaemia.Leuk Lymphoma 1996,23(5–6):423–430. doi:10.3109/10428199609054849
3. Bucek RA, Reiter M, Quehenberger P, Minar E, Baghestanian M: The role of soluble cell adhesion molecules in patients with suspected deep vein thrombosis.Blood Coagul Fibrinolysis 2003,14(7):653–657. doi:10.1097/01.mbc.0000061340.72909.51 10.1097/00001721-200310000-00006
4. Coleman DM, Wakefield TW: Biomarkers for the diagnosis of deep vein thrombosis.Expert Opin Med Diagn 2012,6(4):253–257. doi:10.1517/17530059.2012.692674 10.1517/17530059.2012.692674
5. Delehedde M, Devenyns L, Maurage CA, Vives RR: Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan.Int J Cell Biol 2013, 2013:705027. doi:10.1155/2013/705027
6. Ferrara JL, Harris AC, Greenson JK, Braun TM, Holler E, Teshima T, Levine JE, Choi SW, Huber E, Landfried K, Akashi K, Vander Lugt M, Reddy P, Chin A, Zhang Q, Hanash S, Paczesny S: Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease.Blood 2011,118(25):6702–6708. doi:10.1182/blood-2011–08–375006 10.1182/blood-2011-08-375006
7. Fox EA, Kahn SR: The relationship between inflammation and venous thrombosis. A systematic review of clinical studies.Thromb Haemost 2005,94(2):362–365. doi:10.1267/THRO05020362
8. Goodacre S, Stevenson M, Wailoo A, Sampson F, Sutton AJ, Thomas S: How should we diagnose suspected deep-vein thrombosis?QJM: monthly journal of the Association of Physicians 2006,99(6):377–388. doi:10.1093/qjmed/hcl051 10.1093/qjmed/hcl051
9. Guzel A, Duran L, Koksal N, Torun AC, Alacam H, Ekiz BC, Murat N: Evaluation of serum endothelial cell specific molecule-1 (endocan) levels as a biomarker in patients with pulmonary thromboembolism.Blood Coagul Fibrinolysis 2014,25(3):272–276. doi:10.1097/MBC.0000000000000071 10.1097/MBC.0000000000000071
10. Harris AC, Ferrara JL, Braun TM, Holler E, Teshima T, Levine JE, Choi SW, Landfried K, Akashi K, Vander Lugt M, Couriel DR, Reddy P, Paczesny S: Plasma biomarkers of lower gastrointestinal and liver acute GVHD.Blood 2012,119(12):2960–2963. doi:10.1182/blood-2011–10–387357 10.1182/blood-2011-10-387357
11. Hatfield KJ, Lassalle P, Leiva RA, Lindas R, Wendelboe O, Bruserud O: Serum levels of endothelium-derived endocan are increased in patients with untreated acute myeloid leukemia.Hematology 2011,16(6):351–356. doi:10.1179/102453311X13127324303434 10.1179/102453311X13127324303434
12. Hou H, Ge Z, Ying P, Dai J, Shi D, Xu Z, Chen D, Jiang Q: Biomarkers of deep venous thrombosis.J Thromb Thrombolysis 2012,34(3):335–346. doi:10.1007/s11239–012–0721-y 10.1007/s11239-012-0721-y
13. Levine JE, Logan BR, Wu J, Alousi AM, Bolanos-Meade J, Ferrara JL, Ho VT, Weisdorf DJ, Paczesny S: Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study.Blood 2012,119(16):3854–3860. doi:10.1182/blood-2012–01–403063 10.1182/blood-2012-01-403063
14. Paczesny S, Levine JE, Braun TM, Ferrara JL: Plasma biomarkers in graft-versus-host disease: a new era?Biol Blood Marrow Transplant 2009,15(1 Suppl):33–38. doi:10.1016/j.bbmt.2008.10.027
15. Reikvam H, Tiu RV: Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera.Leukemia 2012,26(4):563–571. doi:10.1038/leu.2011.314 10.1038/leu.2011.314
16. Sarrazin S, Adam E, Lyon M, Depontieu F, Motte V, Landolfi C, Lortat-Jacob H, Bechard D, Lassalle P, Delehedde M: Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy.Biochim Biophys Acta 2006,1765(1):25–37. doi:10.1016/j.bbcan.2005.08.004
17. Shapiro NI, Trzeciak S, Hollander JE, Birkhahn R, Otero R, Osborn TM, Moretti E, Nguyen HB, Gunnerson KJ, Milzman D, Gaieski DF, Goyal M, Cairns CB, Ngo L, Rivers EP: A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis.Crit Care Med 2009,37(1):96–104. doi:10.1097/CCM.0b013e318192fd9d 10.1097/CCM.0b013e318192fd9d
18. Skibsted S, Shapiro NI: Transcriptomics may pave the biomarker road in sepsis*.Crit Care Med 2014,42(4):974–975. doi:10.1097/CCM.0000000000000198 10.1097/CCM.0000000000000198
19. Stavrum AK, Petersen K, Jonassen I, Dysvik B: Analysis of Gene-Expression Data Using J-Express. Current Protocols in Bioinformatics/Editoral Board, Andreas D Baxevanis [et al.] Chapter 7:Unit 7 3. 2008. doi:10.1002/0471250953.bi0703s21
20. Tenna AM, Kappadath S, Stansby G: Diagnostic tests and strategies in venous thromboembolism.Phlebology/Venous Forum of the Royal Society of Medicine 2012,27(Suppl 2):43–52. doi:10.1258/phleb.2012.012S35
21. Uitte de Willige S, De Visser MC, Vos HL, Houwing-Duistermaat JJ, Rosendaal FR, Bertina RM: Selectin haplotypes and the risk of venous thrombosis: influence of linkage disequilibrium with the factor V Leiden mutation.J Thromb Haemostasis 2008,6(3):478–485. doi:10.1111/j.1538–7836.2007.02879.x 10.1111/j.1538-7836.2007.02879.x
22. Van Bijnen ST, Van Heerde WL, Muus P: Mechanisms and clinical implications of thrombosis in paroxysmal nocturnal hemoglobinuria.J Thromb Haemostasis 2012,10(1):1–10. doi:10.1111/j.1538–7836.2011.04562.x 10.1111/j.1538-7836.2011.04562.x
23. Wong HR, Salisbury S, Xiao Q, Cvijanovich NZ, Hall M, Allen GL, Thomas NJ, Freishtat RJ, Anas N, Meyer K, Checchia PA, Lin R, Shanley TP, Bigham MT, Sen A, Nowak J, Quasney M, Henricksen JW, Chopra A, Banschbach S, Beckman E, Harmon K, Lahni P, Lindsell CJ: The pediatric sepsis biomarker risk model.Crit Care 2012,16(5):R174. doi:10.1186/cc11652 10.1186/cc11652
24. Wong HR, Lindsell CJ, Pettila V, Meyer NJ, Thair SA, Karlsson S, Russell JA, Fjell CD, Boyd JH, Ruokonen E, Shashaty MG, Christie JD, Hart KW, Lahni P, Walley KR: A multibiomarker-based outcome risk stratification model for adult septic shock*.Crit Care Med 2014,42(4):781–789. doi:10.1097/CCM.0000000000000106 10.1097/CCM.0000000000000106